Market Entry Target the $5B knee treatment market with KneeStim as a mobile rehabilitation solution for conservative, cost- and time-efficient knee care, highlighting compatibility with wearable tech and at-home therapy to appeal to providers and payers seeking outpatient alternatives.

Clinical Validation Leverage independent market validation, prospective FDA clearance pathways, and identified reimbursement codes to build credibility with clinicians and purchasing committees, accelerating pilot programs and hospital deployments.

Tech Differentiator Position as a wearable NMES-enabled rehabilitation device that converts daily activity into therapeutic sessions, emphasizing machine learning driven personalization to differentiate from traditional braces and static therapy devices.

Strategic Partnerships Pursue collaborations with medical device design partners, rehabilitation clinics, and payer networks to co-develop clinical protocols, generate real-world evidence, and unlock faster reimbursement and adoption.

Growth Readiness Capitalize on existing traction with prototypes, patents, and awards to support investor and customer confidence while targeting lean, high-impact pilots with small- to mid-sized clinics and specialty knee centers.